Atomwise logo

Atomwise Inc.


Atomwise Stock

Atomwise is an artificial intelligence (AI)-driven drug discovery company harnessing the power of deep learning and massive computational resources for the development of novel pharmaceuticals. Its proprietary platform, AtomNet, utilizes techniques mimicking molecular recognition to screen vast libraries of chemical compounds.

Founded: 2012

Atomwise Website

Management Team

Abraham Heifets, Ph.D. Co-Founder and CEO
Izhar Wallach, Ph.D. Co-Founder and CTO
Gavin Hirst, Ph.D. Chief Scientific Officer
Neely Mozaffarian, M.D., Ph.D. Chief Medical Officer

Funding Information